BIOMARIN PHARMACEUTICAL INC.
BMRN · NASDAQ
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
Market Data
Price
$61.80
+0.92 (+1.51%)
Market Cap$11.71B
P/E Ratio33.56
EPS$—
52W High$73.51
52W Low$50.76
Beta0.25
Data from Finnhub · Updated Mar 10, 2026